These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2324520)

  • 21. Concanavalin A-dependent cell-mediated cytotoxicity in bronchoalveolar lavage fluid. Correlation with lung allograft rejection in mongrel dogs during cyclosporine dose tapering.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    Transplantation; 1986 Nov; 42(5):466-72. PubMed ID: 3538531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of cyclosporine on humoral and cellular alloreactivity to allogeneic pregnancy in rats.
    Cunningham C; Thomson AW; Power DA; Mason RJ; Catto GR
    Transplantation; 1986 Oct; 42(4):400-3. PubMed ID: 3490022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival.
    Tchervenkov JI; Epstein MD; Alexander JW; Schroeder TJ
    Transplantation; 1989 Jan; 47(1):177-81. PubMed ID: 2643225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Transplantation; 1988 Jun; 45(6):1131-5. PubMed ID: 3289153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
    Kupiec-Weglinski JW; Heidecke CD; Araujo JL; Abbud-Filho M; Towpik E; Araneda D; Strom TB; Tilney NL
    Cell Immunol; 1985 Jun; 93(1):168-77. PubMed ID: 3158407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.
    Kawashima H; Mochizuki M; Okumura A; Fujino Y; Tange T; Horiuchi D; Higashihara E; Kaku H; Inaba G
    Jpn J Ophthalmol; 1989; 33(4):425-40. PubMed ID: 2625778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial tolerance in rat renal allograft recipients following multiple blood transfusions and concomitant cyclosporine.
    Hewitt CW; Black KS; Harman JC; Beko KR; Lee HS; Patel AP; Martin DC
    Transplantation; 1990 Jan; 49(1):194-8. PubMed ID: 2301011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.
    Hall BM; Pearce NW; Gurley KE; Dorsch SE
    J Exp Med; 1990 Jan; 171(1):141-57. PubMed ID: 2136906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation.
    Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS
    Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine.
    Martinelli GP; Chung-Loy R; Sher L; Racelis D; Miller CM; Schanzer H
    Transplantation; 1985 Jan; 39(1):1-5. PubMed ID: 3880956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of combined application of external cyclosporine A and CTLA4Ig on the survival of rat auricle allograft].
    Cao C; Li SR; Sun ZC; Wang ZX; Luo GX; Wu J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jul; 16(4):281-3. PubMed ID: 12181799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differences.
    Miyagawa S; Stepkowski SM; Lawen JG; Rutzky LP; Kahan BD
    Transplantation; 1991 Nov; 52(5):851-7. PubMed ID: 1835196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
    Ueda H; Hancock WW; Cheung YC; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
    Transplantation; 1990 Oct; 50(4):545-50. PubMed ID: 2219270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and function of suppressor T lymphocytes in immunologically unresponsive rats following pretreatment with UV-B-irradiated donor leukocytes and peritransplant cyclosporine.
    Oluwole SF; Reemtsma K; Hardy MA
    Transplantation; 1989 Jun; 47(6):1001-7. PubMed ID: 2525288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.